GLP-1 drugs may reduce surgery complications in patients with diabetes, suggests study Dr. Kamal Kant Kohli15 Jan 2025 8:45 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
Copycat weight-loss drugs: Eli Lilly sues two medical spas Ruchika Sharma14 Jan 2025 5:28 PM ISTTwo medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in...
GLP-1 Drugs May Lower Surgical Complications in Diabetes Patients: Study Finds Dr. Bhumika Maikhuri9 Jan 2025 8:15 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
Tirzepatide taken for weight loss may lead to Colonic Ischemia: Case report Dr.Niharika Harsha B23 Dec 2024 9:15 AM ISTA recent case published in the journal ACG CASE REPORTS JOURNAL found a possible risk of colonic ischemia caused by the usage of tirzepatide for...
USFDA approves Eli Lilly weight loss treatment Zepbound for obstructive sleep apnea Ruchika Sharma21 Dec 2024 1:30 PM ISTstyle="text-align: justify; ">Indianapolis: Eli Lilly and Company has announced the U.S. Food and Drug Administration (FDA) has...
Eli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen Susmita Roy17 Dec 2024 6:00 PM ISTNew Delhi: The pharmaceutical major Eli Lilly and Company (India) has got the go-ahead from the Subject Expert Committee (SEC) functional under the...
Tirzepatide versus Semaglutide- Surmount-5 trial reveals head-on comparison results Dr. Prem Aggarwal5 Dec 2024 12:00 PM ISTUS: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company announced that participants...
24 year old starts weight loss journey with Tirzepatide, suffers acute liver Injury: Case report Medha Baranwal28 Nov 2024 12:45 PM ISTKuwait: A case study published in the European Journal of Case Reports in Internal Medicine highlights the importance of healthcare practitioners...
Tirzepatide can reduce mortality risk among heart failure with preserved heart function and obesity: Study Dr. Kamal Kant Kohli22 Nov 2024 10:00 PM ISTWeight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart...
Tirzepatide Demonstrates Long-Term Weight Reduction and Diabetes Risk Reduction in Obesity and Prediabetes: NEJM Medha Baranwal15 Nov 2024 9:00 AM ISTUSA: In recent years, medical advancements have provided new hope for the management of obesity and the prevention of type 2 diabetes, with...
Eli Lilly sues vendors for selling copy of its popular weight loss drug Zepbound MD Bureau22 Oct 2024 3:12 PM ISTLilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products claiming to contain...
Real-World Analysis of Tirzepatide Reveals Comparable Safety Profile to GLP-1 Receptor Agonists Medha Baranwal20 Sept 2024 9:30 AM ISTItaly: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety profile of tirzepatide...
